Leukemia News

Allogeneic hematopoietic stem cell transplantation after CD19 chimeric antigen receptor T-cell therapy is thought to improve leukemia-free survival.

As the broader health care field strives to identify and address health care disparities, a commentary published in The Lancet Oncology underscored the importance of eliminating ableism from cancer care.

The proportion of individuals with newly diagnosed cancer who lacked insurance in the U.S. declined significantly from 2010 to 2019, according to data published in Health Affairs Scholar.

Cancer research and advocacy funding disproportionately skewed toward certain subtypes, leaving many cancers with high mortality rates and those affecting Black patients underfunded, study results in JCO Oncology Practice showed.

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

The FDA has requested manufacturers of commercially available chimeric antigen receptor T-cell therapies now include a boxed safety warning regarding the risk for secondary T-cell malignancies on prescribing labels.

SAN DIEGO — Akriti Jain, MD, highlights presentations from ASH Annual Meeting and Exposition focused on triplet combination therapy for patients with acute myeloid leukemia.

SAN DIEGO — Akriti Jain, MD, spoke with Healio about combination therapy with venetoclax for acute myeloid leukemia presented at ASH Annual Meeting and Exposition.

SAN DIEGO — In this video, Akriti Jain, MD, discusses a new targeted monotherapy being used for patients with acute myeloid leukemia, tuspetinib.

SAN DIEGO — In this video, Akriti Jain, MD, provides two updates on intensive treatment regimens for acute myeloid leukemia presented at ASH Annual Meeting and Exposition.